Clinical Trials Logo

Aortic Valve Stenosis clinical trials

View clinical trials related to Aortic Valve Stenosis.

Filter by:

NCT ID: NCT02781896 Completed - Clinical trials for Aortic Valve Stenosis

Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI

EASY TAVI
Start date: May 12, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a left ventricular rapid pacing using the valve delivery guide-wire in transcatheter aortic valve implantation (TAVI) reduces the overall procedure duration in comparison with the conventional method.

NCT ID: NCT02760771 Completed - Aortic Stenosis Clinical Trials

Transfemoral Transcatheter Aortic Valve Implantation With or Without Predilation of the Aortic Valve (EASE-IT TF)

EASE-IT-TF
Start date: May 2016
Phase: N/A
Study type: Observational [Patient Registry]

Prior to the deployment of transcatheter heart valves (THV), balloon aortic valvuloplasty (BAV) is often performed under rapid right ventricular pacing (burst >180 bpm) with the induction of a functional cardiac arrest for up to 30 seconds. Aortic valve predilation aims at facilitating the crossing of the aortic annulus, accurate valve positioning and does also provide information on the anatomy of the valve complex. However, BAV has been shown to have a number of potentially detrimental effects. There is limited experience for the balloon expandable Edwards THV on the need for predilation (BAV). Experience so far has only been documented from smaller, uncontrolled case series. The investigators aim to document the incidence of several kinds of complications in a large, multicenter registry / prospective controlled cohort study to identify associations between patient related variables and outcomes.

NCT ID: NCT02758964 Completed - Clinical trials for Aortic Valve Stenosis

Evaluation of Cerebral Thrombembolism After TAVR

EARTH - TAVR
Start date: September 2016
Phase:
Study type: Observational

EARTH-TAVR is a diagnostic multicenter study to evaluate the occurrence and extent of cerebral embolization (total new lesion volume) in patients before TAVR versus 3 months after TAVR.

NCT ID: NCT02746809 Completed - Clinical trials for Aortic Valve Stenosis

Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)

Start date: June 2016
Phase: N/A
Study type: Interventional

The study objectives are to assess the safety and efficacy of the CoreValve Evolut 34R transcatheter aortic valve replacement (TAVR) system in patients with severe symptomatic aortic stenosis who are considered at high or extreme risk for surgical aortic valve replacement.

NCT ID: NCT02745314 Completed - Aortic Stenosis Clinical Trials

Frailty and Mortality in Older Old With Severe Aortic Stenosis

SAS-frailty
Start date: February 2010
Phase: N/A
Study type: Observational

BACKGROUND.- The frailty syndrome (FS) associates an increase in morbidity and mortality in the elderly patient. When severe and symptomatic, aortic stenosis (AS) is a disease with poor prognosis, the most frequent cause of heart surgery in the elderly and associates high health costs. No variables have been identified as determinants of morbidity and mortality of these patients and there are not algorithms developed for treatment decision-making in this particular population. The FS as a functional reserve indicator could be a prognostic and interventional treatment tolerance marker, and should be included in the selection of patients for surgical treatment. The FS and cardiovascular disease (CVD) share biological substrates among which an inflammatory state associates poor prognosis. OBJECTIVES .- To evaluate the effectiveness of the diagnosis of FS to characterize the prognosis of elderly patients with severe symptomatic AS representative of clinical practice. In addition, to examine the contribution of an inflammatory state to the relationship of FS with the prognosis of severe, symptomatic AS. METHODS .- Prospective study during 12 months of 200 patients > 74 years old with severe symptomatic AS. During the index visit the main clinical characteristics will be recorded and in addition we will perform a comprehensive geriatric assessment, FS assessmet according to Fried et al criteria (strength, walking speed, physical activity, fatigue, unintentional weight loss) and determination of inflammatory markers (C-reactive protein and interleukin-6). During follow-up, measures of functional impairment (basic and instrumental activities of daily living, walking speed and timed set up & go test), hospitalizations, death and quality of life will be determined.

NCT ID: NCT02738853 Completed - Clinical trials for Aortic Valve Stenosis

The Medtronic TAVR 2.0 US Clinical Study

Start date: April 2016
Phase: N/A
Study type: Interventional

The study objective is to evaluate safety and efficacy of the Medtronic TAVR (Transcatheter Aortic Valve Replacement) 2.0 system in patients with severe symptomatic aortic stenosis who are considered at high through extreme risk for surgical aortic valve replacement

NCT ID: NCT02729519 Completed - Clinical trials for Aortic Valve Stenosis

TAVI Without Balloon Predilatation (of the Aortic Valve ) SAPIEN 3

DIRECTAVI
Start date: June 8, 2016
Phase: N/A
Study type: Interventional

Balloon predilatation of the aortic valve has been regarded as an essential step during the transcatheter aortic valve implantation (TAVI) procedure. However, recent evidence suggested that aortic valvuloplasty may be harmful and that high success rate may be obtained without prior dilatation of the valve. We hypothesize that TAVI performed without predilatation and using new generation balloon expandable prothesis is associated with a better net clinical benefit in comparison with procedure performed with pre dilatation.

NCT ID: NCT02727504 Completed - Clinical trials for Aortic Valve Stenosis

Low Flow Low Gradient Aortic Stenosis Relevance of the (re)Search for a Contractile Reserve

LOWAS
Start date: May 11, 2016
Phase:
Study type: Observational

Investigators sought to demonstrate that the increase in the stroke volume during a dobutamine stress echocardiography might impact the prognosis of a patient addressed for a low flow low gradient suspected severe aortic valve stenosis.

NCT ID: NCT02726087 Completed - Clinical trials for Aortic Valve Stenosis

Quality of Life After Ministernotomy Versus Full Sternotomy Aortic Valve Replacement

QUALITY-AVR
Start date: March 20, 2016
Phase: N/A
Study type: Interventional

This is a single-center, single-blind, all comer, randomized controlled trial. Patients scheduled for isolated aortic valve replacement (AVR) due to aortic stenosis at "Virgen de la Victoria Universitary Hospital", Málaga, Spain, will be eligible. Ninety-six patients will be randomly assigned to either partial upper sternotomy (ministernotomy, 48 patients) or full sternotomy AVR (48 patients). Sample size was determined for an Alpha error of 0.05,and Beta error of 0.1 for a power of 90% in detecting 0.10 difference points in quality of life EQ-5D-5L-index or 10 points in EQ-5D-5L-Visual Analogic Scale (QOL).

NCT ID: NCT02698956 Completed - Aortic Stenosis Clinical Trials

SOURCE 3: Observational Study to Evaluate Safety and Performance of SAPIEN 3 THV System in Real Life Practice

SOURCE 3
Start date: July 2014
Phase:
Study type: Observational

This is an international, mutli-center, prospective, consecutively enrolled, observational registry. 2000 patients are planned to be enrolled over one year at up to 150 participating sites. 300 patients out of the 2000 patients enrolled in the main registry are planned to be consecutively enrolled in a select few sites for studying the valve performance. Echocardiogram and angiogram will be taken routinely.